Denali Therapeutics, Inc. (DNLI)

16.81 -0.66 (-3.78%) USD  |  NASDAQ  |  Dec 23, 16:00
16.82 +0.01 (+0.06%) After-Hours: 20:00
More

Denali Therapeutics SG&A Expense (TTM): 127.16M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Enovis Corp. 1.057B
Masimo Corp. 596.30M
Novavax, Inc. 201.70M
iRhythm Technologies, Inc. 470.32M
Twist Bioscience Corp. 246.98M